Clinical trial
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
NCT01452152 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- February 29, 2012
- Completion date
- July 31, 2013
- Enrollment
- 9 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.